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Intr
Currently there is controversy about criteria for blood
transfusion in critically ill patients by a level of hemoglo-
bin and specially as a strategy to raise the venous oxygen
saturation (Sv02).
Objectives
To analyze de utility of the venoarterial carbon dioxide
gradient (V-a PC02) to detect those patients who will
respond with a rise of Sv02 to blood transfusion.
Methods
Patients within their first 12 hours from admission to the
intensive care unit (ICU) during the hemodynamic optimi-
zation protocol in which blood transfusion was decided to
rise the Sv02 after hemodynamic optimization: central
venous pressure (CVP)>8 mmHg, mean arterial pressure
(MAP)>65 mmHg, peripheral oxygen saturation (Sp02)
>90%. Pre and post transfusion hemoglobin, venous oxy-
gen saturation (Sv02), and V-a PC02 were measured, then
divided in two groups: “Responders” (R) if a rise >5%. In
Sv02 after transfusion was present and in “Non respon-
ders” (NR) with a rise < 5% in Sv02 after transfusion.
Receiver Operating Characteristic (ROC) curve analysis
was performed to asses the utility of the pre transfusion
V-a PC02 as a tool to predict responsiveness of the Sv02
to blood transfusion.
Results
73 patients were analyzed, mean age of 68 ± 2, with
35 (47.9%) males, 25 (34,25%) patients in the R group
and 48 (65,75%) in the NR group.
ROC curve analysis were performed resulting in an area
under the curve of 0.82 (p < 0.01; CI 0.73-0.91) with a pre
transfusion V-a PC02 cutoff value of ≥6 showing a sensi-
bility 66% of and a specificity of 84% for predicting those
patients who will not respond with a rise greater than 5%
in the post transfusion Sv02.
Conclusions
V-a PC02 >6 mmHg identifies those patients that will no
show a rise of the Sv02 as a response to blood transfusion.
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